Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial
Event: ESC Congress 2023
Topic: Lipid-Lowering Agents
Session: Statins, bempedoic acid and ezetimibe: novel findings
